Keith Seidenstricker
Family Medicine · Bakersfield, CANPI 1124183546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 431 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,838 and has fallen 94.7% since, to $151 in 2022. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- Amgen$788
- AstraZeneca$713
- GSK$456
- Lilly USA, LLC$297
- plus $2K from 25 others
What the payments were for
- Food & beverage$6,941100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 101 | $1,431 |
| AbbVie(2 entities) | 98 | $1,224 |
| Amgen | 32 | $788 |
| AstraZeneca | 39 | $713 |
| GSK | 25 | $456 |
| Lilly USA, LLC | 19 | $297 |
| Boehringer Ingelheim | 14 | $279 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $212 |
| Merck | 11 | $185 |
| Amarin Pharma, Inc. | 11 | $181 |
| Supernus Pharmaceuticals, Inc. | 7 | $156 |
| Pfizer | 6 | $122 |
| Sanofi-aventis U.S. LLC | 7 | $116 |
| Biohaven Pharmaceuticals, Inc. | 5 | $111 |
| Nestle Healthcare Nutrition Inc. | 6 | $101 |
| Johnson & Johnson(2 entities) | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $87 |
| Grifols USA, LLC | 3 | $75 |
| Astellas Pharma US Inc | 4 | $72 |
| Ironwood Pharmaceuticals, Inc | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Radius Health, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $18 |
| Nalpropion Pharmaceuticals LLC | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$6,971 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Bakersfield
- Amira AyadBakersfield$360K
- Matthew BeareBakersfield$98K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.